Fakultni Nemocnice V Motole — Clinical Trial Site

297 Registered trials

148 Currently recruiting

Organisation

Fakultni Nemocnice V Motole

Location

Prague, Czechia

Identifier

ORG-100012719

Address

V Uvalu 84/1, Motol, 150 00, Czechia

Departments

#1100: Klinika detske hematologie a onkologie 2. LF UK a FN v Motole
#1108: Kardiologická klinika 2. LF UK a FN Motol
#1602, Onkologicka klinika
#2056: Centrum pro diagnostiku a léčbu demyelinizačních onemocnění
#2700: Urologicka klinika
#2850, ÚLCHKB
#40063; Neurologicka klinika
#40063: Neurologicka klinika
#5002: Ustav imunologie
#7103: Dermatovenerologicke oddeleni
#9152: Dermatovenerologicke oddeleni
1402: Dermatovenerologicke oddeleni
1502: Klinika detske hematologie a onkologie
1600: Klinika detske hematologie a onkologie
1601:Urologicka klinika
1904: Onkologicka klinika
1904:Pneumologicka klinika
2000: Dermatovenerologicke oddeleni
2025: Neurologická klinika 2.LF UK a FN Motol
2044: Oddělení revmatologie dětí a dospělých
2201:Oddělení revmatologie dětí a dospělých
2700: Urologická klinika
2951:ULCHKB
3063:Onkologická klinika
420003: Onkologicka klinika
4504:Dermatovenerologicke oddeleni
6000, Klinika detske hematologie a onkologie
9103; Dermatovenerologicke oddeleni
Cardiology
Clinic of Oncology
Clinic of Urology
CZ10004: Odd.revmatol. deti a dospelych
Department of Cardiology
Department of Immunology
Department of Medical Microbiology
Department of Obstetrics and Gynaecology
Department of Oncology
Department of Oncology 2nd Medical Faculty
Department of Oncology and Radiotherapy
Department of Pediatric hematolog and Oncology
Department of Pediatric Hematology and Oncology
Department of Pediatric Hematology/Oncology
Department of Pediatrics
Department of Urology
Department. Department of Paediatric Haematology and Oncology
Dept of Klinika detske hematologie a onkologie UK
Dermatology
Dermatology and Venereology
Dermatolovenrologické oddělení
Dermatovenerologicke oddeleni
Dermatovenerologické oddělení, V Úvalu 84 150 06 Praha 5 Czech Republic
Dermatovenerologického odděleníI Dermatovenerology Department
Dermatovenerology
Dětské kardiocentrum 2. LF UK a FN Motol
Fakultní nemocnice v Motole
Fakultní nemocnice v Motole Dermatovenerologicke oddeleni
Geriatric Internal Clinic of the 2nd Faculty of Medicine of the UK and Motol General Hospital
III. chirurgicka klinika 1.LF UK a FN Motol
III. chirurgická klinika 1. LF UK a FN Motol
Intensive care unit
Interni klinika
Interní klinika 2. LF UK a FN Motol
Kardiologická klinika
Kardiologicka klinika 2. LF UK a FN Motol
Kardiologické kliniky
Klinika anesteziologie, resuscitace a intenzivní medicíny FN Motol
Klinika detske hematologie a onkologie
Klinika detske hematologie a onkologie 2. LF UK
Klinika dětské hematologie a onkologie 2. LF UK a FN
Klinika dětské hematologie a onkologie 2. LF UK a FN Motol
Klinika dětské hematologie a onkologie 2.LF UK a FN
Klinika dětské hematologie a onkologie UK 2.LF a FN
Klinika dětské hematologie a onkologie/Department of Paediatric Haematology and Oncology
Klinika dětské hematologie a onkologie/Department of Pediatric Hematology and Oncology
Klinika dětské neurologie
Klinika dětské neurologie 2. LF
Klinika dětské neurologie 2.LF UK a FN Motol
Klinika dětské onkologie
Klinika infekčního lékařství a cestovní medicíny
Klinika kardiovaskulární chirurgie
Klinika kardiovaskulární chirurgie 2.LF UK a FN Motol
Klinika onkologie
Klinika ORL a chirurgie hlavy a krku 1. LF UK a FN v Motole
Klinika otorinolaryngologie a chirurgie hlavy a krku
Klinika zobrazovacích metod ě. LF UK FN Motol
Kloinika dětské hematologie a onkologie
NA
Neurologická klinika
Neurologicka klinika 2. LF UK a FN Motol
Neurologická klinika 2.LF UK a FN
Neurologická klinika 2.LF UK a FN Motol
Neurologie - RS centrum
Neurology
Neurology Department
Oční klinika dětí a dospělých 2. LF UK Praha a FN Motol
Oddeleni revmatologie deti a dospelych
ONCOLOGIE
Oncology
Oncology Clinic
Oncology Clinic of the 2nd Faculty of Medicine, Charles University, and Motol University Hospital
Oncology Department
Onkologická klinika
Onkologicka klinika 2. LF a FN Motol
Onkologická klinika 2. LF UK
Onkologická klinika 2. LF UK a FN Motol
Onkologicka klinika 2. LF UK a FN Motol
Onkologická klinika 2. LF UK a FN Motol a Homolka/Oncology clinic 2nd Faculy of Medicine UK and FHMH
Onkologicka klinika 2. LF UK a FN v Motole
Onkologická klinika 2.LF UK a FN Motol
Onkologicke oddeleni
Paediatric Clinic, 2nd Faculty of Medicine, Charles University and Motol University Hospital
Paediatric Department
Paediatric Neurology
Paediatrics
Pediatric Clinic
Pediatric Dermatology
Pediatric Hematology and Oncology
Pediatric Pulmonology
Pediatrická klinika 2. LF UK a FN Motol
Pediatrická hematologie/onkologie
Pediatricka klinika
Pediatrická klinika 2. LF UK a FN Motol
Pediatrická klinika 2. LF UK a FN Motol, V Úvalu 84, 150 06 Praha 5
Pediatrické oddělení
Pneumologická klinika
Pneumologická klinika 2. LF UK a
Pneumologicka klinika 2. LF UK a FN Motol
Pneumologická klinika 2. LF UK a FN Motol, Onkologická ambulance
Pneumologicka klinika 2.LF a FN Motol
Pneumologická klinika 2.LF UK a FN Motol, V Úvalu 84, 150 06 Praha 5
Pneumology Clinic
Pneumology Clinic 2.LF UK and FN Motol
Pneumology department
Pracoviště MOTOL, Onkologická klinika 2. LF Ua FN Motol
reumatology
Rheumatology
Spinální jednotka
Urologicka klinika
Urologická klinika 2. LF UK a FN
Urologická klinika 2. LF UK a FN Motol
Ustav imunologie
Ústav imunologie 2. LF UK a FN Motol
Ustav imunologie 2.LF UK a FN Motol
Ústav lékařské chemie a klinické biochemie
Ústav lékařské chemie a klinické biochemie 2. LF UK a FN Motol
Ústav lékařské mikrobiologie 2. lékařské fakulty UK a centrum cystické fibrózy
Ústav lékařské mikrobiologie 2. LF UK a FN Motol a Homolka, Centrum pro cystickou fibrózu

Clinical trials at this site (297)

Search interface

A clinical trial to provide continued access to remibrutinib (LOU064) for people who are benefiting from it in a previous remibrutinib trial Pending

2025-524078-40-00 Chronic Spontaneous Urticaria 5
Low-dose versus standard-dose anticoagulation with argatroban or enoxaparin during extracorporeal membrane oxygenation controlled by anti-II… Pending

2025-524553-13-00 lung and/or heart failure 4
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Pretreated Unresectable Locally Advanced or Metastatic 10 2026-05-08
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting

2023-508047-40-00 Ovarian cancer 5 2026-04-30
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
Safety, tolerability, pharmacokinetics, and efficacy of filgotinib for the treatment of polyarticular-course juvenile idiopathic arthritis i… Recruiting

2024-511593-70-00 Polyarticular-course juvenile idiopathic arthritis 5 2026-04-27
A study to learn more about how safe finerenone is, when it is taken for a longer time with standard treatment, in children and young adults… Recruiting

2024-519830-22-00 Heart failure due to systemic left ventricular systolic 5 2026-04-27
A Study to Evaluate the Effect of Obicetrapib and Ezetimibe Fixed-Dose Combination (FDC) or Obicetrapib on LDL-C in Participants With Type 2… Recruiting

2025-521936-12-00 Adults with Type 2 Diabetes and/or Metabolic Syndrome 5 2026-04-24
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have … Recruiting

2025-521730-28-00 Colorectal Cancer with Cancer Cachexia 4 2026-03-30
A Long-term Study of Navenibart in Participants with Hereditary Angioedema Recruiting

2025-521142-22-00 Hereditary Angioedema 5 2026-03-27
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 10 2026-03-26
ROSETTA Breast-01: The effects and safety of pumitamig in patients with triple-negative breast cancer Recruiting

2025-521884-12-00 First line triple-negative breast cancer (TNBC) 5 2026-03-19
A clinical study of enlicitide in children with high cholesterol (MK-0616-029) Recruiting

2024-519068-42-00 Heterozygous Familial Hypercholesterolemia in pediatr 10 2026-02-12
STOP-HAE: A Phase 3 Study of ADX-324 in HAE Recruiting

2025-521352-38-00 Hereditary Angioedema 5 2026-01-16
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Framework for Optimizing, Refining, and Unifying Manage 10 2025-12-24
A clinical study of the anti-cancer effects of an investigational therapy or chemotherapy in patients with recurring uterine cancer Recruiting

2023-507525-42-00 Endometrial cancer 5 2025-12-23
A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment Recruiting

2024-517923-38-00 Newly diagnosed and/or previously treated IDH1-mutated 3 2025-12-10
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-… Recruiting

2025-520982-39-00 Philadelphia Chromosome Positive or ABL-class Philadelp 5 2025-12-09
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 10 2025-11-28
A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis Recruiting

2024-519795-11-00 Atopic Dermatitis 4 2025-10-06
Phase 3 Study of T-DXd and Rilvegostomig versus Standard of Care in Advanced HER2-expressing Biliary Tract Cancer Recruiting

2023-508057-19-00 Advanced HER2-expressing Biliary Tract Cancer 5 2025-09-23
Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR) Recruiting

2024-520107-12-00 Hidradenitis Suppurativa // Prurigo Nodularis // Vitili 5 2025-09-03
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
A Study to Learn About the Study Medicine Called Sigvotatug Vedotin in People with Locally Advanced, Unresectable, or Metastatic Non-Small C… Recruiting

2024-517968-36-00 non-small cell lung cancer 5 2025-07-08